Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Intestinal transcription and synthesis of apolipoprotein AI is regulated by five natural polymorphisms upstream of the apolipoprotein CIII gene.
S Naganawa, … , R M Glickman, G S Ginsburg
S Naganawa, … , R M Glickman, G S Ginsburg
Published April 15, 1997
Citation Information: J Clin Invest. 1997;99(8):1958-1965. https://doi.org/10.1172/JCI119363.
View: Text | PDF
Research Article

Intestinal transcription and synthesis of apolipoprotein AI is regulated by five natural polymorphisms upstream of the apolipoprotein CIII gene.

  • Text
  • PDF
Abstract

To understand the factors contributing to the synthesis of human apolipoprotein AI (apoAI), relative apoAI synthesis was measured from endoscopic biopsy samples obtained from 18 healthy volunteers. The relative amount of apoAI synthesis was directly correlated with steady state intestinal apoAI mRNA levels and a 10-fold within-group variability was observed. Analysis of genomic DNA from the subjects revealed five polymorphic sites which defined two haplotypes in the intestinal enhancer region of the apoAI gene located upstream of the apolipoprotein CIII gene transcriptional start site (+ 1): (-641 C to A, -630 G to A, -625 T to deletion, -482 C to T, and -455 T to C). The population frequencies of the wild-type and mutant alleles were 0.53 and 0.44, respectively. Mean steady state apoAI mRNA levels and mean relative apoAI synthesis were 49 and 37% lower, respectively, in homozygotes for the mutant allele and 28 and 41% lower, respectively, in heterozygotes than in homozygotes for the wild-type allele (P < 0.05 for both). Site-directed mutants of apoAI gene promoter/reporter constructs containing the above mutations were transfected into Caco-2 cells and showed a 46% decrease in transcriptional activity compared with the wild type (P < 0.001); however, no significant differences were observed in HepG2 cells. Electrophoretic mobility shift assays showed that the mutated sequences from -655 to -610 bound Caco-2 cell nuclear protein(s) while the wild type did not. These results indicate that intestinal apoAI gene transcription and protein synthesis are genetically determined and are reduced in the presence of common mutations which induced binding of nuclear protein(s), possibly a transcriptional repressor.

Authors

S Naganawa, H N Ginsberg, R M Glickman, G S Ginsburg

×

Total citations by year

Year: 2015 2014 2012 2011 2007 2006 2005 2004 2002 2001 1999 1998 1997 Total
Citations: 1 1 1 1 2 1 2 1 2 3 3 1 1 20
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (20)

Title and authors Publication Year
Elevated interleukin-10: A new cause of dyslipidemia leading to severe HDL deficiency
AG Moraitis, LA Freeman, RD Shamburek, R Wesley, W Wilson, CM Grant, S Price, S Demosky, SG Thacker, A Zarzour, RL Hornung, F Pucino, G Csako, C Yarboro, IB McInnes, T Kuroiwa, D Boumpas, VK Rao, GG Illei, AT Remaley
Journal of Clinical Lipidology 2015
Elevated interleukin-10: A new cause of dyslipidemia leading to severe HDL deficiency
AG Moraitis, LA Freeman, RD Shamburek, R Wesley, W Wilson, CM Grant, S Price, S Demosky, SG Thacker, A Zarzour, RL Hornung, F Pucino, G Csako, C Yarboro, IB McInnes, T Kuroiwa, D Boumpas, VK Rao, GG Illei, AT Remaley
Journal of Clinical Lipidology 2014
Long-Range Regulatory Polymorphisms Affecting a GABA Receptor Constitute a Quantitative Trait Locus (QTL) for Social Behavior in Caenorhabditis elegans
A Bendesky, J Pitts, MV Rockman, WC Chen, MW Tan, L Kruglyak, CI Bargmann, M Hammarlund
PLoS genetics 2012
Genetics and molecular biology
J Pétremand, C Widmann
Current Opinion in Lipidology 2011
Apolipoprotein AI-CIII-AIV gene cluster polymorphisms in relation to cholesterol gallstone
YG YAO, X QIU, MK MA, DS PU, LJ XIAO
Journal of Digestive Diseases 2007
Association between the -455T>C promoter polymorphism of the APOC3gene and the metabolic syndrome in a multi-ethnic sample
RL Pollex, MR Ban, TK Young, P Bjerregaard, SS Anand, S Yusuf, B Zinman, SB Harris, AJ Hanley, PW Connelly, MW Huff, RA Hegele
BMC Medical Genetics 2007
Associations among Race/Ethnicity, ApoC-III Genotypes, and Lipids in HIV-1-Infected Individuals on Antiretroviral Therapy
AS Foulkes, DA Wohl, I Frank, E Puleo, S Restine, ML Wolfe, MP Dube, P Tebas, MP Reilly
PLoS Medicine 2006
The APOA1/C3/A4/A5 gene cluster, lipid metabolism and cardiovascular disease risk
CQ Lai, LD Parnell, JM Ordovas
Current Opinion in Lipidology 2005
Low HDL Cholesterol Levels
MD Ashen, RS Blumenthal
New England Journal of Medicine 2005
Effect of glucosamine on apolipoprotein AI mRNA stabilization and expression in HepG2 cells
MJ Haas, NC Wong, AD Mooradian
Metabolism 2004
Abundant Raw Material for Cis-Regulatory Evolution in Humans
MV Rockman, GA Wray
Molecular Biology and Evolution 2002
Análisis de las regiones reguladoras de la expresión de apo A-I en sujetos con hipoalfalipoproteinemia
D Recalde, A Cenarro, AL García-Otín, T Tejedor, F Civeira, M Pocoví
Clínica e Investigación en Arteriosclerosis 2002
Prevalence of the APOC3 promoter polymorphisms T-455C and C-482T in Asian-Indians
M Miller, J Rhyne, M Khatta, H Parekh, K Zeller
The American Journal of Cardiology 2001
Intestinal Lipid Metabolism
CM Mansbach, P Tso, A Kuksis
2001
Genetic heterogeneity in the apolipoprotein C-III promoter and effects of insulin
GM Dallinga-Thie, M Groenendijk, RN Blom, TW Bruin, ED Kant
Journal of lipid research 2001
Novel genes for familial combined hyperlipidemia
BE Aouizerat, H Allayee, J Bodnar, KL Krass, L Peltonen, TW de Bruin, JI Rotter, AJ Lusis
Current Opinion in Lipidology 1999
A Bifunctional Regulatory Element of the Human ApoA-I Gene Responsive to a Distal Enhancer
DR Jones, M Leffak
DNA and Cell Biology 1999
Association of plasma lipids and apolipoproteins with the insulin response element in the apoC-III promoter region in familial combined hyperlipidemia
M Groenendijk, R, NH Blom, JI Rotter, TW de Bruin, GM Dallinga-Thie
Journal of lipid research 1999
The effect on transcription efficiency of the apolipoprotein AI gene of DNA variants at the 5′ untranslated region
XL Wang, RB Badenhop, AS Sim, DE Wilcken
International Journal of Clinical & Laboratory Research 1998
The Human CC Chemokine Receptor 5 (CCR5) Gene: MULTIPLE TRANSCRIPTS WITH 5′-END HETEROGENEITY, DUAL PROMOTER USAGE, AND EVIDENCE FOR POLYMORPHISMS WITHIN THE REGULATORY REGIONS AND NONCODING EXONS
S Mummidi, SS Ahuja, BL McDaniel, SK Ahuja
The Journal of biological chemistry 1997

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts